Domenica Caramazza

Varese, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.

Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.

Journal: Blood advances
Published: October 01, 2024

Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET survey.

Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET survey.

Journal: European journal of haematology
Published: April 10, 2024

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry.

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry.

Journal: Research and practice in thrombosis and haemostasis
Published: January 19, 2023

Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients.

Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients.

Journal: Leukemia
Published: May 07, 2022

Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.

Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.

Journal: Annals of hematology
Published: May 19, 2020

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

Journal: American journal of hematology
Published: August 27, 2017

The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda".

The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda".

Journal: Leukemia research
Published: July 07, 2015

JAK inhibitor in CALR-mutant myelofibrosis.

JAK inhibitor in CALR-mutant myelofibrosis.

Journal: The New England journal of medicine
Published: March 21, 2014

It is time to change thrombosis risk assessment for PV and ET?

It is time to change thrombosis risk assessment for PV and ET?

Journal: Best practice & research. Clinical haematology
Published: February 17, 2014

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts.

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts.

Journal: Blood
Published: January 21, 2014

Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases.

Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases.

Journal: Thrombosis research
Published: September 10, 2013

Novel agents in indolent lymphomas.

Novel agents in indolent lymphomas.

Journal: Therapeutic advances in hematology
Published: April 24, 2013
Showing 1-12 of 16

Last Updated: 09/26/2026